Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masson, S.
Right arrow Articles by Newsome, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masson, S.
Right arrow Articles by Newsome, P. N.

Stem Cells 2004;22:897-907 www.StemCells.com
© 2004 AlphaMed Press


CONCISE REVIEW

Potential of Hematopoietic Stem Cell Therapy in Hepatology: A Critical Review

Steven Massona, David J. Harrisonb, John N. Plevrisa, Philip N. Newsomea,b

a Department of Hepatology, Chancellor’s Building, University of Edinburgh, Edinburgh, Scotland;
b Centre for Inflammation Research, University of Edinburgh, Edinburgh, Scotland

Key Words. Bone marrow • Cell differentiation • Cell fusion • Hematopoietic stem cells Hepatocytes • Liver regeneration • Stem cells

Correspondence: Philip Newsome, M.D., Ph.D., Department of Hepatology, Chancellor’s Building, University of Edinburgh, Edinburgh EH16 4SB, U.K. Telephone: 0044-131-242-1712; Fax: 0044-131-242-1633; e-mail: P.Newsome{at}ed.ac.uk

Adult stem cell plasticity raised expectations regarding novel cellular therapies of regenerative medicine after findings of unexpected plasticity were reported. In this review, reports of hematopoietic stem cells (HSCs) contributing to hepatocytic lineages are critically discussed with reference to rodent and human models. In particular, the role of liver injury and the potential contribution HSCs make to hepatic regeneration in both injury and physiological maintenance is reviewed. The relative contributions of genomic plasticity and cell fusion are studied across different model systems, highlighting possible factors that may explain differences between often conflicting reports. Insights from experimental studies will be described that shed light on the mechanisms underlying the migration, engraftment, and transdifferentiation of HSCs in liver injury. Although it appears that under differing circumstances, macrophage fusion, HSC fusion, and HSC transdifferentiation can all contribute to hepatic epithelial lineages, a much greater understanding of the factors that regulate the long-term efficacy of such cells is needed before this phenomenon can be used clinically.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 2004 by AlphaMed Press.